Skip to main content
رجوع
IART logo

Integra LifeSciences Holdings Corporation

جودة البيانات: 100%
IART
NASDAQ Healthcare Medical - Devices
KWD 9.55
▲ KWD 0.01 (0.10%)
القيمة السوقية: 744.30M
نطاق اليوم
KWD 9.18 KWD 9.70
نطاق 52 أسبوعًا
KWD 8.70 KWD 22.96
حجم التداول
599,290
متوسط 50 يوم / 200 يوم
KWD 11.06 / KWD 12.79
الإغلاق السابق
KWD 9.54

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -1.4 0.3
P/B 0.7 3.0
ROE % -39.9 3.7
Net Margin % -31.6 3.8
Rev Growth 5Y % 1.5 10.0
D/E 2.0 0.2

السعر المستهدف للمحللين

Hold
KWD 15.00 +57.1%
مكرر الربحية المستقبلي
4.07
ربحية السهم المستقبلية
KWD 2.35
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.67B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 KWD 2.74
KWD 2.71 – KWD 2.76
1.78B 1
FY2027 KWD 2.55
KWD 2.49 – KWD 2.62
1.73B 5
FY2026 KWD 2.35
KWD 2.30 – KWD 2.37
1.67B 6

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 KWD 0.80 KWD 0.83 +3.8%
2025-10-30 KWD 0.43 KWD 0.54 +25.6%
2025-07-31 KWD 0.43 KWD 0.45 +4.7%
2025-05-05 KWD 0.43 KWD 0.41 -4.7%
2025-02-25 KWD 0.86 KWD 0.97 +12.8%
2024-11-04 KWD 0.39 KWD 0.41 +5.1%
2024-07-29 KWD 0.62 KWD 0.63 +1.6%
2024-05-06 KWD 0.55 KWD 0.55 0.0%

Insider Trading Activity

20 transactions
Date Insider Type Shares Price Value
Mar 11, 2026
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
grant 70,305
Mar 11, 2026
Knight Lea Daniels
EVP & Chief Financial Officer
other 8,089 KWD 9.61 KWD 77,735.29
Mar 11, 2026
Knight Lea Daniels
EVP & Chief Financial Officer
grant 111,179
Mar 11, 2026
DAVIS ROBERT T. JR.
EVP & President, TT
other 8,487 KWD 9.61 KWD 81,560.07
Mar 11, 2026
DAVIS ROBERT T. JR.
EVP & President, TT
grant 43,350
Mar 11, 2026
McBreen Michael J.
EVP & President, CSS
other 7,247 KWD 9.61 KWD 69,643.67
Mar 11, 2026
McBreen Michael J.
EVP & President, CSS
grant 92,108
Mar 10, 2026
DAVIS ROBERT T. JR.
EVP & President, TT
other 687 KWD 9.55 KWD 6,560.85
Mar 10, 2026
McBreen Michael J.
EVP & President, CSS
other 2,354 KWD 9.55 KWD 22,480.70
Feb 2, 2026
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
grant 89,606
Nov 5, 2025
GRAVES JEFFREY A
Director
buy 9,000 KWD 11.35 KWD 102,150.00
Oct 12, 2025
Singh Harvinder
EVP & PRESIDENT, INTERNATIONAL
other 27,211
Jul 3, 2025
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
other 3,345 KWD 13.49 KWD 45,124.05
Jul 3, 2025
Knight Lea Daniels
EVP & Chief Financial Officer
other 2,561 KWD 13.49 KWD 34,547.89
Jul 1, 2025
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
other 937 KWD 13.25 KWD 12,415.25
May 9, 2025
BRADLEY KEITH
Director
other 392 KWD 12.25 KWD 4,802.00
May 9, 2025
BRADLEY KEITH
Director
grant 19,592
May 9, 2025
HILL BARBARA B
Director
grant 26,531
May 9, 2025
Clay Shaundra
Director
grant 19,592
May 9, 2025
Lo Renee Wonlai
Director
grant 19,592

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 1.47% annually over 5 years — modest growth
Negative free cash flow of -31.05M
Capital efficient — spends only 4.98% of revenue on capex
ROIC of 1.67% — low return on invested capital
Interest coverage of 0.79× — tight debt servicing

النمو

Revenue Growth (5Y)
1.47%
Revenue (1Y)1.53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-39.90%
ROIC1.67%
Net Margin-31.58%
Op. Margin4.18%

الأمان

Debt / Equity
1.95
Current Ratio2.54
Interest Coverage0.79

التقييم

P/E Ratio
-1.44
Forward P/E4.02
P/B Ratio0.71
EV/EBITDA37.21
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.53% Revenue Growth (3Y) 2.99%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 1.47% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.64B Net Income (TTM) -516.47M
ROE -39.90% ROA -14.34%
Gross Margin 51.69% Operating Margin 4.18%
Net Margin -31.58% Free Cash Flow (TTM) -31.05M
ROIC 1.67% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.95 Current Ratio 2.54
Interest Coverage 0.79
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.44 Forward P/E 4.02
P/B Ratio 0.71 P/S Ratio 0.46
PEG Ratio 0.00 Forward PEG N/A
EV/EBITDA 37.21 Fwd EV/EBITDA 13.29
Forward P/S 0.44 Fwd Earnings Yield 24.88%
FCF Yield -4.17%
Market Cap 744.30M Enterprise Value 2.54B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.64B 1.61B 1.54B 1.56B 1.54B
Net Income -516.47M -6.94M 67.74M 180.55M 169.08M
EPS (Diluted) -6.73 -0.09 0.84 2.16 1.98
Gross Profit 845.23M 882.06M 884.74M 970.31M 944.64M
Operating Income 68.32M 28.41M 111.53M 238.92M 197.23M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.60B 4.04B 3.78B 3.89B 3.78B
Total Liabilities 2.56B 2.49B 2.19B 2.09B 2.10B
Shareholders' Equity 1.04B 1.55B 1.59B 1.80B 1.68B
Total Debt 2.03B 1.98B 1.68B 1.63B 1.67B
Cash & Equivalents 235.05M 246.38M 276.40M 456.66M 513.45M
Current Assets 1.16B 1.08B 1.06B 1.16B 1.15B
Current Liabilities 455.98M 922.13M 306.98M 320.91M 340.02M